Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07535502

Food is Medicine in Pediatric Patients With Diabetes

The objective of this randomized controlled trial is to evaluate the effect of novel Food is Medicine Programming in the form of medically tailored pre-packaged meals for pediatric patients with Type 1 Diabetes. The provision of medically-tailored meals to children and adolescents with diabetes that have potential food security or access concerns in addition to nutrition counseling will improve clinical outcomes, decrease healthcare utilization, and improve health-related quality of life (HRQOL). Consulting with a Registered Dietician is the established multidisciplinary standard of care for pediatric patients with diabetes at UMass. Community Servings provides a medically-tailored pre-packaged meal plan designed for pediatric patients with Type 1 Diabetes. The addition of Community Servings to the current standard of care in pediatric patients with potential food security or access concerns will further improve clinical, decrease healthcare utilization, and improve HRQOL outcomes in pediatric patients with Type 1 Diabetes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

5 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UMass Memorial Children's Medical Center

Worcester, Massachusetts, 01655, United States

Location contact

Arvin Garg, MD, MPH

PRINCIPAL_INVESTIGATOR

Lawrence Rhein, MD, MPH

PRINCIPAL_INVESTIGATOR

Leslie Soyka, MD

PRINCIPAL_INVESTIGATOR

Madeline E French, BS, MBE

CONTACT

[email protected]

5088870106

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current patients of the UMMMC Pediatric Endocrinology Clinic
  • Children and Adolescents less than or equal to 17 years of age at the time of enrollment
  • Diagnosed with Type 1 Diabetes at least 3 months ago
  • Public (MassHealth or Medicaid) Health Insurance

Exclusion criteria

  • Celiac disease or severe gluten allergy
  • Congenital, genetic, or chronic comorbidities
  • DCF Custody
  • Pregnant women
  • Prisoners
  • Non-English speaking subjects

Treatment and study plan

Community Servings

Other

Participants randomized to the intervention group will receive the Community Servings medically-tailored meal plan for the first 6 months after enrollment. The Community Servings plan will provide 10 medically-tailored meals per week, delivered to the participant residence on the day of the week preferred by the participant. Following enrollment, participants will meet with a Community Servings team member to review dietary restrictions. The meals were designed by Registered Dieticians for children and adolescents with Type 1 Diabetes and will be prepared and distributed by the Community Servings team. Participants in the intervention arm will also be asked to complete a survey on the utility of the Community Servings intervention at the conclusion of the program, 6 months after initial enrollment. The survey and responses will be housed in the REDCap.

PedsQL Survey

Other

All participants or their parents will complete a baseline quality of life assessment appropriate for their age group and again at 3 months, 6 months, and at end of follow-up at 12 months. The PedsQL Measurement Model is a modular approach to measuring health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditions. This model integrates multidimensional physical, emotional, social, and school functioning scales and reports total, physical health, and psychological health summary scores. This survey can be completed in person with research staff, over the phone with research staff, or remotely via a link distributed from the REDCap database. Responses will be stored in the REDCap database.

Nutrition Counseling

Other

Participants will recieve standare-of-care nutrition counseling from a registered dietician with the UMass Pediatric Endocrinology clinic to receive education and review dietary and nutrition recommendations personalized to the patient and management of Type I diabetes.

SDOH Survey

Other

All participants or their parents will complete a baseline social driver of health (SDOH) survey at the time of enrollment and again at 3 months, 6 months, and at end of follow-up at 12 months. The SDOH survey is provided for all patients at UMass and evaluates the risk for food, housing, utility, and transportation concerns. This survey can be completed in person with research staff, over the phone with research staff, or remotely via a link distributed from the REDCap database. Responses will be stored in the REDCap database.

Primary outcomes

  1. Difference in nutrition-related clinical outcomes

    Time frame: 12 months

    The primary outcome measure is the difference in clinical outcomes between the control and intervention groups. Nutrition-related outcomes will include growth metrics (Z-score and percentile rank), and height and weight will be combined to report Body Mass Index (BMI) in kg/m^2 metrics.

  2. Difference in Diabetes-related clinical outcomes

    Time frame: 12 months

    One primary outcome measure is the difference in clinical outcomes between the control and intervention groups. Diabetes outcomes will include changes in insulin dosage (units/mL/day), continuous glucose monitoring metrics (glucose in mg/dL, time spent at range intervals and variability as percentages), and Hemoglobin A1c (percentage).

Secondary outcomes

  1. Healthcare Utilization

    Time frame: 12 months

    A secondary outcome measure is the difference in healthcare utilization outcomes between the control and intervention groups. Healthcare utilization will be determined by additional insulin refill requests, urgent care visits, emergency room visits, and hospital admissions during the study and follow-up period.

  2. HRQOL Outcomes

    Time frame: 12 months

    A secondary outcome measure is the difference in HRQOL outcomes between the control and intervention groups. HRQOL will be determined by the PedsQL survey for the appropriate age group at timepoints 0, 3, 6, and 12 months.

  3. Medically-tailored Meals Sustainability

    Time frame: 12 months

    A secondary outcome measure within the intervention arm only will be a qualitative analysis of the survey responses regarding utility of the Community Servings intervention at conclusion of the intervention to sustainability practices at end of study.

Study contacts

Contact information is provided by the study sponsor or research team.

Madeline E French, BS, MBE

CONTACT

[email protected]

5088870106

Sponsors and collaborators

Lead sponsor

University of Massachusetts, Worcester

Other

Registry information

Official study title

The Effect of a Novel Food is Medicine Program on Outcomes in Pediatric Patients With Diabetes: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2029
First posted
Apr 17, 2026
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.